Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
The researchers suggest that sleep deprivation may exacerbate the inflammatory state associated with obesity by increasing ...
Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...
Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...
Discover a study where findings suggest that strategies targeting visceral fat reduction may aid in overactive bladder ...
Data from the World Population Review for the U.S. and the World Health Organization for Europe reveal that America continues ...
The burden of obesity extends beyond its health effects. For example, a 2024 report estimated that obesity-related healthcare ...
Scientists have discovered new fat cell subpopulations with specialized functions, revealing differences between subcutaneous ...
Obesity trends have stayed stable in the last couple years, whereas severe obesity has trended downward, a recently published report suggested.However, the percentage of people with a healthy weight ...
It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results